Log in or Sign up for Free to view tailored content for your specialty!
Skin Care News
Recessive dystrophic epidermolysis bullosa subtypes linked to type VII protein function
Based on a variant’s impact on type VII collagen protein function, patients with recessive dystrophic epidermolysis bullosa can be categorized into clinically meaningful subgroups to better guide disease management, according to a study.
To test or not to test: Isotretinoin marginally increases risk for severe adverse events
Isotretinoin is associated with a clinically marginal increased risk for severe adverse events, leading researchers to advise routine blood testing commence shortly after initiation, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
Secukinumab fails to meet proof of concept in lichen planus
Secukinumab did not reach proof of concept in patients with lichen planus, according to results of a phase 2 study.
Quality of life measures improve with topical tirbanibulin for actinic keratosis
Actinic keratosis lesions were reduced and quality of life improved following once-daily topical tirbanibulin treatment, according to a study.
OTC healing ointment improves dry skin, surgical wounds
Over-the-counter healing ointment was safe and effective for treating dry, itchy skin and surgical wounds from dermatologic procedures, according to a study.
Physicians recommend skincare regimen for antiaging treatment with energy-based devices
Physicians created an algorithm that provides clinicians with skincare recommendations for facial antiaging treatment with energy-based devices, according to a study.
Erenumab may reduce flushing, erythema in rosacea
Erenumab is potentially efficacious in treating chronic flushing and erythema associated with rosacea, according to a study.
High propranolol initiation dose well tolerated in infantile hemangioma
Initiating infantile hemangioma treatment with propranolol 2 mg/kg per day did not yield more adverse events than 1 mg/kg per day, according to a study.
Nemolizumab filings for prurigo nodularis, atopic dermatitis accepted in four countries
Galderma has received filing acceptances for nemolizumab for the treatment of prurigo nodularis and atopic dermatitis in Australia, Singapore, Switzerland and the United Kingdom, the company announced in a press release.
Q&A: Alcohol consumption can age skin, trigger underlying diseases
Alcohol does more than affect your liver — it can affect your skin too.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read